nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—adrenal gland cancer	0.943	1	CbGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000252	0.0044	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.000251	0.00438	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00025	0.00437	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.000248	0.00433	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000247	0.00432	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000247	0.00431	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—TSHR—adrenal gland cancer	0.000246	0.0043	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000244	0.00427	CbGpPWpGaD
Scopolamine—CHRM1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00024	0.00419	CbGpPWpGaD
Scopolamine—CHRM3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.000239	0.00417	CbGpPWpGaD
Scopolamine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.000237	0.00413	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000237	0.00413	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000236	0.00413	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000228	0.00398	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000227	0.00396	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000226	0.00395	CbGpPWpGaD
Scopolamine—SI—Disease—TERT—adrenal gland cancer	0.000225	0.00394	CbGpPWpGaD
Scopolamine—SI—Metabolism—GNAS—adrenal gland cancer	0.000225	0.00393	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000225	0.00392	CbGpPWpGaD
Scopolamine—SI—Metabolism—ABCB1—adrenal gland cancer	0.000221	0.00385	CbGpPWpGaD
Scopolamine—SI—Disease—BAD—adrenal gland cancer	0.000196	0.00342	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000195	0.0034	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000194	0.00339	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000192	0.00335	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000184	0.0032	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000183	0.00319	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000181	0.00316	CbGpPWpGaD
Scopolamine—SI—Disease—BRAF—adrenal gland cancer	0.000178	0.00312	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000174	0.00304	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.000173	0.00303	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.000173	0.00302	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000171	0.00299	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000167	0.00291	CbGpPWpGaD
Scopolamine—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000166	0.0029	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000166	0.0029	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000164	0.00287	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000164	0.00287	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000163	0.00285	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000159	0.00278	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000159	0.00278	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.000157	0.00275	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000156	0.00273	CbGpPWpGaD
Scopolamine—SI—Metabolism—POMC—adrenal gland cancer	0.000151	0.00264	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00015	0.00261	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000148	0.00259	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.000146	0.00255	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000145	0.00254	CbGpPWpGaD
Scopolamine—SI—Disease—PTGS2—adrenal gland cancer	0.000144	0.00252	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.000143	0.0025	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000142	0.00248	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00014	0.00244	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000139	0.00243	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000136	0.00237	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000135	0.00236	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000132	0.00231	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.000132	0.0023	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00013	0.00227	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00013	0.00226	CbGpPWpGaD
Scopolamine—SI—Disease—CTNNB1—adrenal gland cancer	0.000129	0.00225	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.000128	0.00224	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000128	0.00223	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000127	0.00221	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.000126	0.00221	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000122	0.00213	CbGpPWpGaD
Scopolamine—SI—Metabolism—PTGS2—adrenal gland cancer	0.000121	0.00211	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000111	0.00193	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00011	0.00192	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00011	0.00192	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00011	0.00191	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000109	0.0019	CbGpPWpGaD
Scopolamine—SI—Disease—EGFR—adrenal gland cancer	0.000102	0.00178	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000101	0.00176	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.000101	0.00176	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.000101	0.00176	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	9.98e-05	0.00174	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	9.96e-05	0.00174	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	9.95e-05	0.00174	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	9.85e-05	0.00172	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	9.84e-05	0.00172	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	9.81e-05	0.00171	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	9.8e-05	0.00171	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	9.77e-05	0.00171	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	9.72e-05	0.0017	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	9.67e-05	0.00169	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	9.67e-05	0.00169	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	9.64e-05	0.00168	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	9.47e-05	0.00165	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.15e-05	0.0016	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	9.13e-05	0.00159	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.12e-05	0.00159	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	9.1e-05	0.00159	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9.08e-05	0.00159	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	9.07e-05	0.00158	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.03e-05	0.00158	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	9.01e-05	0.00157	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	8.92e-05	0.00156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	8.9e-05	0.00155	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	8.89e-05	0.00155	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	8.87e-05	0.00155	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	8.85e-05	0.00154	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	8.8e-05	0.00154	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	8.78e-05	0.00153	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	8.75e-05	0.00153	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	8.6e-05	0.0015	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	8.58e-05	0.0015	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	8.49e-05	0.00148	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	8.47e-05	0.00148	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	8.45e-05	0.00148	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	8.38e-05	0.00146	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—RRM1—adrenal gland cancer	8.27e-05	0.00144	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SDHD—adrenal gland cancer	8.27e-05	0.00144	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SDHB—adrenal gland cancer	8.14e-05	0.00142	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	8.09e-05	0.00141	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	8.03e-05	0.0014	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	8e-05	0.0014	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	7.8e-05	0.00136	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	7.69e-05	0.00134	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	7.68e-05	0.00134	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	7.66e-05	0.00134	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	7.47e-05	0.0013	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	7.35e-05	0.00128	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	7.33e-05	0.00128	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	7.02e-05	0.00123	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	6.81e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	6.79e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	6.79e-05	0.00119	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	6.77e-05	0.00118	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	6.7e-05	0.00117	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.68e-05	0.00117	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	6.39e-05	0.00112	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	6.37e-05	0.00111	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	6.3e-05	0.0011	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—MED12—adrenal gland cancer	6.16e-05	0.00108	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.09e-05	0.00106	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	6.03e-05	0.00105	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.98e-05	0.00104	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	5.96e-05	0.00104	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	5.95e-05	0.00104	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	5.9e-05	0.00103	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	5.89e-05	0.00103	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	5.88e-05	0.00103	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	5.82e-05	0.00102	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	5.7e-05	0.000995	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	5.69e-05	0.000994	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	5.68e-05	0.000992	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	5.63e-05	0.000983	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	5.59e-05	0.000977	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	5.45e-05	0.000952	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	5.42e-05	0.000946	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	5.4e-05	0.000943	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	5.39e-05	0.000942	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	5.38e-05	0.000939	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	5.36e-05	0.000936	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	5.35e-05	0.000934	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	5.32e-05	0.00093	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	5.26e-05	0.000918	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.25e-05	0.000916	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.25e-05	0.000916	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	5.24e-05	0.000915	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	5.19e-05	0.000906	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	5.18e-05	0.000904	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	5.17e-05	0.000903	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	5.16e-05	0.000901	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	5.11e-05	0.000892	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	4.95e-05	0.000864	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	4.94e-05	0.000863	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.94e-05	0.000862	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	4.93e-05	0.00086	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	4.88e-05	0.000852	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	4.75e-05	0.000829	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.73e-05	0.000827	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	4.57e-05	0.000799	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	4.54e-05	0.000794	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	4.53e-05	0.000792	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PRKACA—adrenal gland cancer	4.5e-05	0.000785	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	4.42e-05	0.000772	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	4.38e-05	0.000765	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	4.34e-05	0.000758	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	4.24e-05	0.00074	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.98e-05	0.000694	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MED12—adrenal gland cancer	3.91e-05	0.000683	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	3.84e-05	0.00067	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	3.83e-05	0.000668	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	3.81e-05	0.000665	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	3.79e-05	0.000662	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	3.77e-05	0.000659	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	3.76e-05	0.000657	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	3.72e-05	0.00065	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	3.65e-05	0.000637	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—GNAS—adrenal gland cancer	3.64e-05	0.000637	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	3.58e-05	0.000625	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	3.48e-05	0.000609	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	3.47e-05	0.000607	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	3.44e-05	0.000601	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	3.31e-05	0.000578	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	3.2e-05	0.000559	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	3.19e-05	0.000557	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	3.17e-05	0.000554	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	3.16e-05	0.000552	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	3.08e-05	0.000539	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	3.07e-05	0.000537	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	3.06e-05	0.000534	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	3.05e-05	0.000533	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	3.05e-05	0.000532	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	3.04e-05	0.000532	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	3.02e-05	0.000527	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	3.01e-05	0.000526	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	2.98e-05	0.000521	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	2.97e-05	0.000519	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	2.94e-05	0.000514	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	2.92e-05	0.000511	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	2.92e-05	0.00051	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	2.89e-05	0.000504	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.85e-05	0.000498	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	2.8e-05	0.000489	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	2.57e-05	0.000448	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	2.56e-05	0.000447	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	2.53e-05	0.000442	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—POMC—adrenal gland cancer	2.45e-05	0.000429	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.31e-05	0.000404	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	2.23e-05	0.00039	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	2.23e-05	0.000389	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	2.2e-05	0.000385	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	2.18e-05	0.000381	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	2.09e-05	0.000364	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	2.06e-05	0.000359	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	2.05e-05	0.000358	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.03e-05	0.000355	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	2.03e-05	0.000355	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	2.03e-05	0.000354	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	2.01e-05	0.00035	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	1.97e-05	0.000344	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	1.96e-05	0.000343	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	1.96e-05	0.000342	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	1.95e-05	0.00034	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	1.73e-05	0.000301	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	1.65e-05	0.000289	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.56e-05	0.000272	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.47e-05	0.000257	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.46e-05	0.000256	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.45e-05	0.000253	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	1.45e-05	0.000253	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	1.39e-05	0.000242	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.24e-05	0.000217	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-05	0.000203	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	1.16e-05	0.000203	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	1.15e-05	0.000201	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	9.77e-06	0.000171	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	9.74e-06	0.00017	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	9.65e-06	0.000168	CbGpPWpGaD
